Journal of Medicinal Chemistry p. 1613 - 1618 (1993)
Update date:2022-08-03
Topics:
Ohshima
Sato
Obase
Miki
Ishii
Kawakage
Shirakura
Karasawa
Kubo
A new series of 6,11-dihydrodibenz[b,e]oxepin derivatives exerting both thromboxane synthase inhibitory (TXS-I) and thromboxane receptor antagonist (TXRA) activities is described. (-)-11-[(3-Pyridylmethyl)thio]-6,11- dihydrodibenz[b,e]oxepin-2-carboxylic
View MoreShanghai shibo Chemical Co., Ltd
Contact:+86-021-60753516
Address:688 Qiushi Road, Jinshan High-tech Park, Shanghai, China,201512
Shanghai Forever Synthesis Co.,Ltd.
Contact:021-61124658
Address:Zhoukang Road,Pudong New District,Shanghai,China
Zhejiang Newfine Industry Co.,Ltd.
Contact:+86-573-82262042
Address:No.225,Dongqing Road, garoms@163.com
website:https://www.bocsci.com/
Contact:1-631-485-4226
Address:Ramsey Road
Shanghai Norky Pharmaceutical Co., LTD.
website:http://www.norkypharm.com
Contact:86-21-61075300
Address:1165 Jiangning Road, Office 1502, Shanghai, China
Doi:10.1021/om00029a032
(1993)Doi:10.1039/jr9470000433
()Doi:10.1002/recl.19931120211
(1993)Doi:10.1039/J19700002922
()Doi:10.1021/ja00063a009
(1993)Doi:10.1039/c9cc08009k
(2020)
